Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Brianna L Norton

Datos Biográficos

ID6648309
NOMBREBrianna L Norton
NOMBRESBrianna L
APELLIDONorton
FIRMANORTON B L
AFILIACIONESAlbert Einstein College of Medicine
ORCID0000-0002-8287-2245
VERIFICADOSí
TOTAL DE OBRAS12
TOTAL DE CITAS0
TOTAL COMO AUTOR12
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2008
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0
  • Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C

    Open Access•Snehal S Lopes, Irene Pericot-Valverde et al.•ARTICLE•International Journal of…•2026

    Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises

  • Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs

    Open Access•Snehal S Lopes, Irene Pericot-Valverde et al.•ARTICLE•International Journal of Drug…•2024

  • HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy

    Hadi J Minhas, Matthew J Akiyama et al.•ARTICLE•AIDS Care•2022

    Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…

  • Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women

    Open Access•Suzan M Walter, Joey Platt et al.•ARTICLE•AIDS and Behavior•2021

  • High HCV cure rates among people who inject drugs and have suboptimal adherence

    Open Access•Brianna L Norton, Matthew J Akiyama et al.•ARTICLE•International Journal of Drug…•2021

  • Alcohol and Drug Use Surrounding Sex Among Men Who Have Sex with Men in India

    Open Access•Yash Bhambhani, Shruta Rawat et al.•ARTICLE•Sexuality & Culture•2021•Referencias: 2

  • A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection

    Open Access•Oni J Blackstock, Joey Platt et al.•ARTICLE•AIDS and Behavior•2020

  • Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs

    Open Access•Brianna L Norton, Marcus A Bachhuber et al.•ARTICLE•International Journal of Drug…•2019

  • High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

    Open Access•Brianna L Norton, Julia Fleming et al.•ARTICLE•International Journal of Drug…•2017

  • Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

    Open Access•J Grebely, Julie Bruneau et al.•ARTICLE•International Journal of Drug…•2017

  • Evaluation findings on community participation in the California Healthy Cities and Communities program

    Open Access•Michelle C Kegler, John Painter et al.•ARTICLE•Health Promotion International•2009

    As part of an evaluation of the California Healthy Cities and Communities (CHCC) program, we evaluated resident involvement, broad representation and civic engagement beyond the local CHCC initiative. The evaluation design was a case study of 20 participating communities with cross-case analysis. Data collection methods included: coalition member surveys at two points in time, semi-structured interviews with key informants, focus groups with coal…

  • Achieving organizational change

    Open Access•Michelle C Kegler, Brianna L Norton et al.•ARTICLE•Health Promotion International•2008

    As part of an evaluation of the California Healthy Cities and Communities (CHCC) Program, we assessed the extent to which coalitions implementing the healthy cities and communities model demonstrated capacity to leverage financial resources, expand programs and influence organizational policies. The evaluation design was a multiple case study of 20 participating communities with cross-case analysis. Participating communities spanned the state's d…

Sin obras prominentes en esta página.

  • Achieving organizational change

    Open Access•Michelle C Kegler, Brianna L Norton et al.•ARTICLE•Health Promotion International•2008

    As part of an evaluation of the California Healthy Cities and Communities (CHCC) Program, we assessed the extent to which coalitions implementing the healthy cities and communities model demonstrated capacity to leverage financial resources, expand programs and influence organizational policies. The evaluation design was a multiple case study of 20 participating communities with cross-case analysis. Participating communities spanned the state's d…

  • Evaluation findings on community participation in the California Healthy Cities and Communities program

    Open Access•Michelle C Kegler, John Painter et al.•ARTICLE•Health Promotion International•2009

    As part of an evaluation of the California Healthy Cities and Communities (CHCC) program, we evaluated resident involvement, broad representation and civic engagement beyond the local CHCC initiative. The evaluation design was a case study of 20 participating communities with cross-case analysis. Data collection methods included: coalition member surveys at two points in time, semi-structured interviews with key informants, focus groups with coal…

  • High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

    Open Access•Brianna L Norton, Julia Fleming et al.•ARTICLE•International Journal of Drug…•2017

  • Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

    Open Access•J Grebely, Julie Bruneau et al.•ARTICLE•International Journal of Drug…•2017

  • Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs

    Open Access•Brianna L Norton, Marcus A Bachhuber et al.•ARTICLE•International Journal of Drug…•2019

  • A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection

    Open Access•Oni J Blackstock, Joey Platt et al.•ARTICLE•AIDS and Behavior•2020

  • Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women

    Open Access•Suzan M Walter, Joey Platt et al.•ARTICLE•AIDS and Behavior•2021

  • High HCV cure rates among people who inject drugs and have suboptimal adherence

    Open Access•Brianna L Norton, Matthew J Akiyama et al.•ARTICLE•International Journal of Drug…•2021

  • Alcohol and Drug Use Surrounding Sex Among Men Who Have Sex with Men in India

    Open Access•Yash Bhambhani, Shruta Rawat et al.•ARTICLE•Sexuality & Culture•2021•Referencias: 2

  • HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy

    Hadi J Minhas, Matthew J Akiyama et al.•ARTICLE•AIDS Care•2022

    Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…

  • Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs

    Open Access•Snehal S Lopes, Irene Pericot-Valverde et al.•ARTICLE•International Journal of Drug…•2024

  • Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C

    Open Access•Snehal S Lopes, Irene Pericot-Valverde et al.•ARTICLE•International Journal of…•2026

    Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises

Medicine (10 obras) · HIV, Drug Use, Sexual Risk (7 obras) · Family medicine (6 obras) · Hepatitis C virus research (6 obras) · Human immunodeficiency virus (HIV (5 obras) · Internal Medicine (5 obras) · Hepatitis C (4 obras) · HIV/AIDS drug development and treatment (4 obras) · HIV/AIDS Research and Interventions (4 obras) · Psychiatry (4 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae